Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s).
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s).
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Setting Specification Limits for Impurities in Active Pharmaceutical Ingredient (API’s)
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
The subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has continued to receive a large amount of attention from regulators, companies and customers alike.
The integration of Cleaning Validation within an effective Quality System supported by Quality Risk Management Processes should give assurance that API Manufacturing Operations are performed in such a way that Risks to patients related to cleaning validation are understood, assessed for impact and are mitigated as necessary.
It is important that the requirements for the finished manufacturing companies are not transferred back in the process to active pharmaceutical ingredient manufacturers without consideration for the different processes that take place at this stage.
This presentation covers the requirements of Cleaning Validation for a Multipurpose API Manufactuirng Plant
Hướng dẫn Đánh giá hệ thống nước, Tài liệu GMP biên soạn và chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This presentation is produced in the DigiCare project go-funded by Erasmus+ Capacity Building for Higher Education, CBHE.
This is the eighth of ten learning packages produced in the DigiCare project as support materials for implementing the DigiCare model and supporting teachers with ready-made materials.
The learning packages are designed to be adaptable to the specific needs of each Higher Education Institution (HEI) and healthcare student group. While they provide essential information, they are not exhaustive in their coverage. Active pedagogical tools are incorporated into the packages, which can be employed during theory lessons. Each presentation includes a Notes section below the slides, offering ideas for teachers and recommendations for further reading.
The learning packages can be translated, edited, and supplemented with additional content as desired. The packages can be used as a complete set or individually, based on the specific requirements of users. Each learning package is accompanied by an introductory slides and the final slide provides information about the subsequent package in the series.
The A.D.D.I.E. of Developing a Strategic Training RoadmapHenry John Nueva
Whatever size business you run, it is important to remember that learning is an ongoing experience. This applies as much to the upper management of the business as the employees.
It follows that training should also be a part of the company’s day to day business activities. Of course, employees who are motivated and keen to see the business succeed will often take new ideas that they come across during the course of their work, and will sometimes be in a position to make suggestions for improvement that can benefit the company’s bottom line. Check this out !
NAP Training Viet Nam - Session 8 Moving Toward ActionsUNDP Climate
This two-day workshop supported the Government of Viet Nam in building the necessary capacity to advance its National Adaptation Plan (NAP) process. The workshop closely focused on building National Adaptation Plans in the agricultural sector through multi-stakeholder collaboration, and increased knowledge and capacity on a number of topics including: prioritization of adaptation options, cost-benefit analysis, overview of the broad-based nature of climate change adaption impacts, analysis of challenges, and creation of an open discussion with key stakeholders on defining a road-map for the NAP process. The workshop was delivered using discussions and case studies to enhance interactive learning for participants, with supporting presentations by GiZ and SNV.
This presentation is produced in the DigiCare project go-funded by Erasmus+ Capacity Building for Higher Education, CBHE.
This is the ninth of ten learning packages produced in the DigiCare project as support materials for implementing the DigiCare model and supporting teachers with ready-made materials.
The learning packages are designed to be adaptable to the specific needs of each Higher Education Institution (HEI) and healthcare student group. While they provide essential information, they are not exhaustive in their coverage. Active pedagogical tools are incorporated into the packages, which can be employed during theory lessons. Each presentation includes a Notes section below the slides, offering ideas for teachers and recommendations for further reading.
The learning packages can be translated, edited, and supplemented with additional content as desired. The packages can be used as a complete set or individually, based on the specific requirements of users. Each learning package is accompanied by an introductory slides and the final slide provides information about the subsequent package in the series.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
The subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has continued to receive a large amount of attention from regulators, companies and customers alike.
The integration of Cleaning Validation within an effective Quality System supported by Quality Risk Management Processes should give assurance that API Manufacturing Operations are performed in such a way that Risks to patients related to cleaning validation are understood, assessed for impact and are mitigated as necessary.
It is important that the requirements for the finished manufacturing companies are not transferred back in the process to active pharmaceutical ingredient manufacturers without consideration for the different processes that take place at this stage.
This presentation covers the requirements of Cleaning Validation for a Multipurpose API Manufactuirng Plant
Hướng dẫn Đánh giá hệ thống nước, Tài liệu GMP biên soạn và chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This presentation is produced in the DigiCare project go-funded by Erasmus+ Capacity Building for Higher Education, CBHE.
This is the eighth of ten learning packages produced in the DigiCare project as support materials for implementing the DigiCare model and supporting teachers with ready-made materials.
The learning packages are designed to be adaptable to the specific needs of each Higher Education Institution (HEI) and healthcare student group. While they provide essential information, they are not exhaustive in their coverage. Active pedagogical tools are incorporated into the packages, which can be employed during theory lessons. Each presentation includes a Notes section below the slides, offering ideas for teachers and recommendations for further reading.
The learning packages can be translated, edited, and supplemented with additional content as desired. The packages can be used as a complete set or individually, based on the specific requirements of users. Each learning package is accompanied by an introductory slides and the final slide provides information about the subsequent package in the series.
The A.D.D.I.E. of Developing a Strategic Training RoadmapHenry John Nueva
Whatever size business you run, it is important to remember that learning is an ongoing experience. This applies as much to the upper management of the business as the employees.
It follows that training should also be a part of the company’s day to day business activities. Of course, employees who are motivated and keen to see the business succeed will often take new ideas that they come across during the course of their work, and will sometimes be in a position to make suggestions for improvement that can benefit the company’s bottom line. Check this out !
NAP Training Viet Nam - Session 8 Moving Toward ActionsUNDP Climate
This two-day workshop supported the Government of Viet Nam in building the necessary capacity to advance its National Adaptation Plan (NAP) process. The workshop closely focused on building National Adaptation Plans in the agricultural sector through multi-stakeholder collaboration, and increased knowledge and capacity on a number of topics including: prioritization of adaptation options, cost-benefit analysis, overview of the broad-based nature of climate change adaption impacts, analysis of challenges, and creation of an open discussion with key stakeholders on defining a road-map for the NAP process. The workshop was delivered using discussions and case studies to enhance interactive learning for participants, with supporting presentations by GiZ and SNV.
This presentation is produced in the DigiCare project go-funded by Erasmus+ Capacity Building for Higher Education, CBHE.
This is the ninth of ten learning packages produced in the DigiCare project as support materials for implementing the DigiCare model and supporting teachers with ready-made materials.
The learning packages are designed to be adaptable to the specific needs of each Higher Education Institution (HEI) and healthcare student group. While they provide essential information, they are not exhaustive in their coverage. Active pedagogical tools are incorporated into the packages, which can be employed during theory lessons. Each presentation includes a Notes section below the slides, offering ideas for teachers and recommendations for further reading.
The learning packages can be translated, edited, and supplemented with additional content as desired. The packages can be used as a complete set or individually, based on the specific requirements of users. Each learning package is accompanied by an introductory slides and the final slide provides information about the subsequent package in the series.
Report on Fab Labs and Sustainable Development Goals; Workshop; FAB13 Confere...Pieter van der Hijden
FAB13 Workshop: Fab Labs and Sustainable Development Goals (Sustainable Fab Lab Goals / Objetivos de Fab Labs Sostenibles); Report on the workshop during FAB13 conference in Santiago de Chile; 2017; Pieter van der Hijden, Enrico Bassi, Vaneza Caycho Ñuflo, Neville Govender, Yogesh Kulkarni, Wendy Neale.
Template presentation used for the consultation workshops carried out by the RRI Hub members accross Europe on stakeholders' obstacles, opportunities and ideas for RRI in October-November 2014.
Global Health AgendaWhat are some of the opportunities that are av.docxlianaalbee2qly
Global Health Agenda
What are some of the opportunities that are available to develop an interdisciplinary approach to the advance of the World Health Organization (WHO) global health agenda? Describe how the application of multiculturalism and diversity practices and policies can impact the organization you work in respect to those opportunities. Summarize what you have learned in this course to advance how the role of an advance practice nurse can influence this global approach. This is the conclusion to this class. See the different themes we studied to finish this assignment.
Unit 1:
Advance Practice Nurses and Public Policy
·
Listen to the Audio/visual Course Overview.
·
Read the Unit Overview.
·
Complete the Activities.
·
Participate in the Discussion.
·
Participate in the Seminar.
Discussion Board
Unit 2:
Policy Design, Implementation and Program Evaluation
Read the Overview.
Complete the Activities.
Participate in the Discussion.
Complete group contract (template provided).
Discussion Board
Unit 3:
Markets, Funding and Financial Models
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
·
Complete the Assignment.
Discussion Board
Assignment
Unit 4:
Financial Models of Reimbursement and Effects on Patients and Healthcare Providers
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
Discussion Board
Unit 5:
Health Policies and Organizational Structures
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion
·
Participate in the Seminar.
Discussion Board
Unit 6
: Healthcare Policy Models and Theories
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
·
Complete the Assignment.
Discussion Board
Assignment
Unit 7:
Healthcare Reform
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion
·
Participate in the Seminar.
Discussion Board
Unit 8:
Incorporating Genetics Research into Practice
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
Discussion Board
Unit 9:
Inter-professional Practice
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
·
Complete the Assignment.
Discussion Board
Assignment
Unit 10:
Global Connections
·
Read the Overview.
·
Complete the Activities.
·
Participate in the Discussion.
Discussion Board
.
Similar to Giới thiệu về khóa học | Tài liệu GMP (20)
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận đủ điều kiện kinh doanh dược đối với cơ sở sản xuất thuốc, nguyên liệu làm thuốc
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thuốc” (GMP) đối với cơ sở không thuộc diện cấp chứng nhận đủ điều kiện kinh doanh dược
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Module 1 | Slide 2 of 17 January
2006
Basic Principles of GMP
Introduction
to the Training Course
3. Module 1 | Slide 3 of 17 January
2006
Introduction
Objectives of this Introductory Session
To outline the programme
To introduce your trainers
To introduce you to one another and to understand your
objectives and background
To understand the way these modules work
4. Module 1 | Slide 4 of 17 January
2006
Introduction
Programme Overview – I
Basic Principles of GMP
WHO Technical Report Series, No. 908, 2003, Annex 4
1. Introduction to the training programme
2. Quality Management
3. Sanitation and hygiene
4. Qualification and Validation
5. Complaints and recalls
5. Module 1 | Slide 5 of 17 January
2006
Introduction
Programme Overview – II
Basic Principles of GMP
6. Contract production and analysis
7. Self Inspection and quality audits
8. Personnel
9. Premises
10. Equipment
6. Module 1 | Slide 6 of 17 January
2006
Introduction
Programme Overview – III
Basic Principles of GMP
11. Materials
12. Documentation
13. Good Practices in production and quality control
14. Sterile production
15. Active pharmaceutical ingredients
7. Module 1 | Slide 7 of 17 January
2006
Introduction
Programme Overview – IV
GMP Inspection Process
16. Introduction
17. The role of the inspector
18. Preparation for the inspection
19. Types of GMP inspection
20. The inspection
Trainers’ notes
8. Module 1 | Slide 8 of 17 January
2006
Introduction
Your Team
Who are we?
Trainers
(Name)
(Qualifications)
(Experience)
(Name)
(Qualifications)
(Experience)
9. Module 1 | Slide 9 of 17 January
2006
Introduction
Who am I?
Name
Experience
Objectives
Not a lot of people know ………..
10. Module 1 | Slide 10 of 17 January
2006
Introduction
Objectives of the training course
To introduce general elements on quality management
To train you in the WHO GMP texts for pharmaceutical products
To bring in your own experience
To develop your own action plan
11. Module 1 | Slide 11 of 17 January
2006
Introduction
Our Way of Working
A presentation on the subject of the module - usually about
60 minutes
follows the WHO text as the basis of the module
will have the WHO reference at the bottom of the slide
A 30-60 minute group session discussing issues or a problem that
will be set for you
Group feedback in plenary session
Multiple choice quiz
12. Module 1 | Slide 12 of 17 January
2006
Introduction
How the Group Session and Feedback works
Move to your area and select a group chairperson, a timekeeper, a recorder
and reporter to present the group’s views to the combined meeting
Identify the issues to be discussed
Discussion:
fundamental to the learning process
needs enthusiastic participation
needs a “brainstorming approach”
Document the group’s views on 1 flip-chart page
Maximum of 10 minutes for each group’s presentation
13. Module 1 | Slide 13 of 17 January
2006
Introduction
Working in Groups
Please accept shared responsibility in each group for:
Dialogue
Shared ideas
Shared understanding
Shared meaning
Clarifying
Participation
Enabling others to
participate
Active listening
Agreeing to disagree
14. Module 1 | Slide 14 of 17 January
2006
Introduction
Working in Groups
When someone says something which does not agree with your
views ….
or seems wrong to you .…
Do not immediately say
“That’s wrong” or “How stupid”
Pause; Reflect
“What do they really mean?”
Say instead
“An interesting idea” or
“that’s a different way of looking at it”
15. Module 1 | Slide 15 of 17 January
2006
Introduction
Group Session
Discuss the GMP issues you each face in your own countries
Identify key objectives to be achieved in attending this programme at a:
Regional level
National level
Organizational level
Personal level
16. Module 1 | Slide 16 of 17 January
2006
Introduction
Group Session
Identify key objectives to be achieved in attending this programme, at
a Regional level, at a National level, at an Organizational level and at
a Personal level.
Set objectives using the SMART formula:
Specific
Measurable
Action-oriented
Realistic
Time-related
17. Module 1 | Slide 17 of 17 January
2006
Introduction
Group Session
Identify key objectives to be achieved in attending this programme, at
a Regional level, at a National level, at an Organizational level and at
a Personal level.
Objectives should be developed in the SMART format:
Specific, Measurable, Action-oriented, Realistic, Time-related
Identify 3 success criteria by which the objective will be measured.
Please observe the times allowed:
1 hour maximum discussion
5 - 10 minutes maximum feedback for each group
Editor's Notes
Welcome
Good morning and welcome to all delegates to this training course offered by the World Health Organization to develop the practical implementation of the WHO GMP text of Good Manufacturing Practice for Pharmaceutical Products.
Thanks
Our thanks to ______________________ for the arrangements that have been made to accommodate us all for the duration of the programme.
Housekeeping
(cover fire or emergency procedures, and domestic arrangements including location of toilet facilities, tea or coffee breaks, meal breaks)
Objectives
I propose to review first of all the objectives that have been established for this training programme. These are to outline the programme and to describe the qualities that your team members bring to the programme.
(Introduce trainers)
We would also find it most valuable if we could understand something about you, why you are here and what you want to get from this training programme. In this way we hope to ensure that you get what you want from the programme. Additionally it will help us and your fellow trainees to know your area of expertise, so that we may all learn from one another.
It is also important that you have an understanding of how the modules are constructed, and our way of working in groups. I will explain a little later about some team rules which are essential if you are to obtain the most benefit from this GMP course.
My colleagues and I are also available to be consulted individually on any matter if you feel we can help in any way. Please make maximum use of the opportunity to exchange experiences with all of us.
We shall start by reviewing the programme and introduce our interactive way of working together. We will explain the way the group discussions will work.
Modules 1-14 cover the basic principles of GMP.
There will be a half-day module on Quality Management and the requirements for a quality assurance unit. You will need to have a clear understanding of the organizational structures that must be in place if a pharmaceutical company is to have the product quality that is required by the National Health Regulator.
We shall look at complaint handling procedures and product recall procedures that you should expect pharmaceutical companies to have. This ensures that complaints are properly handled and that patients are protected from dangerous or substandard medicines that have been placed on the market by a proper recall system.
This will be followed by a half-day session on Sanitation and Hygiene.
Next we will spend a half-day looking at Validation.
We then have a half-day module on Contract Production and Analysis. This is becoming much more important all over the world as companies decide not to manufacture all their own products in their own factories or manufacturing sites. This means that companies are putting more and more work out to contractors. Companies are also contracting out analytical work as methods become more complex or use expensive equipment. All of this contract work requires careful your inspection.
Next we will have a short session on Self-inspection.
We then turn to the topic of Personnel. Personnel should be seen by the pharmaceutical manufacturer as its most valuable resource. It is sometimes its most difficult one to manage. Inspectors need to be sure that there are sufficient human resources, with people who have the correct qualifications and acceptable levels of experience. An important issue for you to check is the conflict of interest that can arise if Quality Control is not properly independent of Production. For this reason a full day is required for this subject.
This will be followed by a half-day session on Equipment. If you would like to have any particular piece of equipment discussed please write its name down and hand it to me at the end of this module. If possible we will discuss the item during the Equipment module.
We shall then spend a full day on Premises. Here we are going to be looking at some of the fundamental issues, including the effect of the external environment, on a company’s ability to manufacture products in the appropriate conditions.
This will be followed by a half-day session on Materials. Experience has shown that many problems arise as a result of the selection of unsuitable or impure materials. Many developing countries have financial constraints that work against using materials of the right quality.
Documentation: This short module covers the design and use of documentation -- often poorly done, especially in less developed countries. Correct recording of activities as they occur is vital for the production and testing of products to meet GMP standards.
The full-day module on Sterile Production will look at the very demanding activities required to achieve the highest standards. There are special demands that these very important products make upon a company’s resources and systems. Companies are often tempted to take shortcuts because of the expense involved and you will have to know where to look to see if the companies are strictly following Good Manufacturing Practices.
A half-day module on Active Pharmaceutical Ingredients is covered next. This is an area where regulatory authorities should be increasing their inspection activities. It is a vital area for proper drug efficacy. If poor quality actives are used then the drug attributes sometimes cannot be tested for later on when the material is compounded into product. A problem at a later stage is also more expensive to detect and correct.
Personal objectives: On completion of the GMP Basic Training Modules, we shall distribute a Personal Action Plan form in order to check your understanding of the materials, and to give you the opportunity to develop your personal action plans.
Modules 15-20 cover the G MP Inspection Process. Modules 15-19 consist of short sessions on:
. an introduction to the topic
. the role of the inspector
. preparation for the inspection
. types of GMP inspection
. the inspection
and will take approximately one-and-a-half days to complete.
Module 20 provide trainer’s notes.
THIS SLIDE (or overhead transparency) IS AN EXAMPLE ONLY AND HAS NOT BEEN PROVIDED IN THE PACK – YOU SHOULD PREPARE AN APPROPRIATE VERSION FOR EACH COURSE.
First of all a few details about each of your team members.
(The team members are to introduce themselves with a short review of their background and experience, giving training, qualifications, organizations worked with, and any other relevant details. Get them to also reveal something personal, such as a hobby.)
(Note to the trainer: This is a good ice-breaker. Get the trainees used to speaking to the whole group. Give each trainee only 2 or 3 minutes each, a little longer if at all possible. You may need to allow a little for time depending on the language ability of the participants.)
In order that we can all become better acquainted, I would like you to tell us your name, your experience to date in manufacturing and/or GMP inspection, your objectives for attending this training programme and a little something about you that no one else in the room knows – YET!
When we were preparing for this training programme, we were aware that it had to be of value to you, our participants. We felt very strongly that it must provide information and experience sharing in a form that you will want to take away with you and use again and again.
These are the objectives that we have for this programme:
We aim to provide you with a training programme to ensure that you have an understanding of all aspects of the WHO recommendations on GMP for pharmaceutical products. However, these recommendations have to be applied in the real world in which you live. For this reason we have developed the programme in such a way that your input will be an important element.
The programme has been designed to enable you to bring in your real life experiences, so that we can see how you will respond to these real challenges.
A training programme is only of value if, as a result of the training, you change your behaviour. To encourage such a change, we will be asking you to prepare your own personal action plan as we work through the training.
Note for the trainer: The form for the action plan should be contained in the trainee’s registration material. It is suggested that you have an overhead of this and go through its layout at this point
You have each been provided with a form for your own personal action plan: things to do as a result of this training programme. If any of you would like help in creating this action plan please see any member of the team during training. We would recommend that you compile this plan as we go along and not leave it all to the end.
You will be expected to discuss this action plan with your supervisor on your return to your office and then regularly to review your progress with him or her.
The modules start with a presentation which follows the WHO text. A reference number to the WHO text is always given in a text box at the bottom of the slide.
There follows a group discussion. We have placed you into small groups and designated a room or an area for you to work in. On the next slide we will talk about the most effective ways to have a group discussion.
Each group will be asked to present its findings before the other groups in what is sometimes referred to as a plenary session. We will allow 5 - 10 minutes for each group to make its presentation.
At the end of each of the modules on Basic Principles of GMP (except this one) there is a set of simple multiple choice questions to complete. We will then go through the answers with you and discuss any questions you may have about them. Many previous groups have found test answer session one of the most informative parts of the programme.
At the end of each session on the theory of the WHO text, we will put up an overhead to remind you which group you are in, which area or room you should go to, and the key issues to be discussed.
Please help us to keep to time by moving quickly to your area.
Your group must first appoint a chairperson, a timekeeper to keep you on track, a recorder and someone to present your conclusions.
Then discuss the issues.
These group discussions are considered to be:
fundamental to the learning process
need enthusiastic participation
needs a “brainstorming approach
We recommend the technique of “brainstorming” using a flip-chart to get all the issues out into the open quickly. I should just like to check if everyone is familiar with brainstorming and the rules that apply to it.
(Note to the trainer: If necessary advise how brainstorming is undertaken using a flipchat.)
At the end of your group discussions, you will come back here for a session at which the conclusions from each group will be presented to everyone. This will last at the most, 30 minutes.
Some trainees may get suppressed by more dominating trainees. A few group rules are useful. Trainers tip: Provide slides 11 and 12 as fullpage handouts.
Dialogue: make sure that the groups are not monopolized by one participant
Shared ideas: encourage participants to share experiences or to advance their ideas even if they seem a little silly. Make sure that they record all ideas, no matter how strange they may seem. Some explanation of brainstorming may be needed.
Shared understanding: some participants in each group may have a good understanding of the subject and should be encouraged to explain the concepts.
Shared meaning: If some of the group has a better understanding of the meaning of a concept, encourage them to share this with the group.
Clarifying: make clear the meanings
Participation: Each person should be encouraged to participate in the groups work.
Enabling others to participate: Some participants through shyness of language barriers may feel left out. It is important that the groups draw these people into the discussions as much as possible.
Active listening means concentrating on what they are saying, asking questions such as “I take it that you mean … by your statement”, or “I see” or “could you explain that another way perhaps”
Agreeing to disagree: sometimes, inevitably, there comes a time when some people within a group just cannot agree. This is sometimes quite acceptable because GMP is not a black and white subject. However, it is important that when this situation arises that the people respect that the other person has a right to hold a certain interpretation and so still agree to disagree.
Its OK to disagree within a group. However, try to understand the other person’s point of view.
Trainer’s tip: this slide may have to be ordered with the Personal level coming first, depending on the nature and background of the participants. The Regional and National level may have to be explained or a global perspective can sometimes be encouraged where there are countries with factories are exporting (or want to export) products around the world.
For our first group session we want to you to familiarize yourself with the brainstorming technique and the way of working in groups. You need to learn how to work with your groups members to achieve a good result together. Please use this session to start this process.
Your task in your groups is to to discuss the current GMP situation in your country.
We wish to know the following:
1. What do you consider to be your key objectives for this programme?
2. What you will use to measure the success or otherwise of the whole programme?
Discuss the SMART approach to setting objectives. Example: I want to prepare two GMP training modules for use in my own country by the year 2003. Show how this is specific, measurable, action-oriented, realistic and time based.
Identify 3 criteria by which you will measure the effect.
You have 1 hour for this activity and you should return with 1 flip-chart sheet to be presented in a maximum of 5 - 10 minutes (Note: you may have to allow a little longer for discussion or for other matters such as language problems) in the plenary session.
Here is a list of the members of each group and your group room numbers. You have one hour for the discussion and then we shall meet back here for the group feedback session. We hope that you will enjoy our training programme and gain valuable insights that will help you in your work in the future.